Global Automated Cell Cultures Market
Market Size in USD Billion
CAGR :
% 
USD
14.13 Billion
USD
27.95 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 14.13 Billion |
 Market Size (Forecast Year) |
USD 27.95 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Automated Cell Cultures Market Segmentation, By Products (Instruments, Reagents and Kits, and Others), Type (Automated Cell Culture Storage Equipment, Automated Cell Culture Vessels, Automated Cell Culture Supporting Instruments, Bioreactors), Application (Drug Development, Stem Cell Research, Regenerative Medicine, Cancer Research, Vaccines, and Others), End User (Biotech Companies, Research Organizations, Academic Research Institutes, and Other) - Industry Trends and Forecast to 2032
Automated Cell Cultures Market Size
- The global automated cell cultures market size was valued at USD 14.13 billion in 2024 and is expected to reach USD 27.95 billion by 2032, at a CAGR of 8.90% during the forecast period
- This growth is driven by factors such as the increasing demand for cell-based therapies, advancements in automation technologies, and the need for reproducibility and scalability in research and production processes
Automated Cell Cultures Market Analysis
- Automated cell cultures refer to systems and technologies that automate the processes involved in growing and maintaining cell cultures in laboratory settings
- These systems typically involve automated platforms that control environmental conditions such as temperature, humidity, and CO2 levels, as well as automated handling of cell culture vessels, media changes, and monitoring of cell growth and viability
- North America is expected to dominate the automated cell cultures market with 40.5% due to advanced healthcare infrastructure, significant investments in biopharmaceutical research
- Asia-Pacific is expected to be the fastest growing region in the automated cell cultures market during the forecast period due to Government initiatives to promote biotechnology and life sciences, along with the establishment of biopharmaceutical manufacturing hubs
- Instruments segment is expected to dominate the market with a market share due to systems require specialized instruments such as bioreactors, incubators, and automated cell handling systems for various cell-based applications
Report Scope and Automated Cell Cultures Market Segmentation
|
Attributes |
Automated Cell Cultures Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Automated Cell Cultures Market Trends
“Technological Advancements in Automation”
- The incorporation of artificial intelligence (AI) and machine learning (ML) into automated cell culture systems is enhancing real-time monitoring, predictive analytics, and optimization of culture conditions
- Cloud-based platforms enable remote monitoring, centralized data storage, and seamless collaboration across research teams, facilitating continuous improvement and scalability
- Advanced robotic systems are streamlining cell handling processes, reducing human error, and increasing throughput in cell culture operations
- The development of compact, high-throughput systems is making automated cell culture more accessible to smaller laboratories and research institutions
- Automated systems are increasingly integrating with analytical tools such as mass spectrometry and high-content imaging to provide comprehensive data for cell analysis
Automated Cell Cultures Market Dynamics
Driver
“Increasing Demand for Biopharmaceuticals”
- The global increase in chronic diseases is driving the demand for biopharmaceuticals, including monoclonal antibodies and vaccines, which require scalable and efficient cell culture processes
- Personalized medicine approaches necessitate the production of patient-specific cell therapies, further fueling the need for automated cell culture systems
- Automated systems enable high-throughput screening and rapid production, crucial for accelerating drug discovery and development, thereby driving market growth
- Regulatory agencies are providing guidelines and support for the development and approval of biopharmaceuticals, encouraging investment in automated cell culture technologies
- Increased investment in research and development by pharmaceutical companies is promoting the adoption of automated cell culture systems to streamline production processes
Opportunity
“Adoption of 3D Cell Culture Techniques”
- Three-dimensional (3D) cell culture techniques more accurately replicate in vivo environments, improving the relevance of experimental results
- 3D cultures provide more reliable models for drug screening, reducing the likelihood of late-stage clinical trial failures
- The integration of 3D cell culture with tissue engineering is enabling the development of complex tissue models for regenerative medicine
- Companies are developing and commercializing automated 3D cell culture systems, expanding market opportunities in this segment
- Collaborations between academic institutions and industry players are accelerating the development and adoption of 3D cell culture technologies
Restraint/Challenge
“High Capital Investment and Skilled Workforce Shortage”
- Implementing automated cell culture systems involves significant upfront costs, including the purchase of equipment, software, and maintenance expenses
- Ongoing operational costs, such as consumables and energy consumption, can be prohibitive for small and medium-sized laboratories
- The complexity of automated systems requires a skilled workforce proficient in both biological sciences and automation technologies
- Investing in training programs to upskill existing staff adds to operational expenses and implementation timelines
- Ensuring compliance with stringent regulatory standards necessitates specialized knowledge and can delay the adoption of automated systems
Automated Cell Cultures Market Scope
The market is segmented on the basis of products, type, application, and end user.
|
Segmentation |
Sub-Segmentation |
|
By Products |
|
|
By Type |
|
|
By Application |
|
|
By End User |
|
In 2025, the instruments is projected to dominate the market with a largest share in products segment
The instruments segment is expected to dominate the automated cell cultures market with the largest share in 2025 due to systems require specialized instruments such as bioreactors, incubators, and automated cell handling systems for various cell-based applications. The demand for high-precision instruments is driven by their crucial role in scaling production and ensuring reproducibility, especially in biopharmaceutical production.
The bioreactors is expected to account for the largest share during the forecast period in type market
In 2025, the bioreactors segment is expected to dominate the market with the largest market share due to its vital for maintaining the controlled environment required for cell growth and are used extensively in large-scale production of biologics and vaccines. Bioreactors are essential in both research and commercial manufacturing, which gives them a significant market share.
Automated Cell Cultures Market Regional Analysis
“North America Holds the Largest Share in the Automated Cell Cultures Market”
- North America holds the largest share of the global automated cell culture market, accounting for 40.5%
- The region's dominance is attributed to advanced healthcare infrastructure, significant investments in biopharmaceutical research, and the presence of major market players
- North America leads in the adoption of cutting-edge technologies in life sciences, with a strong focus on innovation and automation
- The U.S., in particular, is at the forefront, with substantial funding for research initiatives and a well-established network of research institutions and biopharmaceutical companies
- Favorable government policies and funding initiatives further support the widespread adoption of automated cell culture systems in North America
“Asia-Pacific is Projected to Register the Highest CAGR in the Automated Cell Cultures Market”
- The Asia-Pacific region is expected to witness the fastest growth in the automated cell culture market
- Countries such as China, India, and Japan are leading contributors, driven by increasing investment in healthcare infrastructure and rising demand for biopharmaceuticals
- Government initiatives to promote biotechnology and life sciences, along with the establishment of biopharmaceutical manufacturing hubs, are propelling market growth
- Growing research activities in the region are creating a significant demand for efficient and scalable cell culture solutions
- The adoption of automation in cell culture processes is gaining traction as local companies strive to improve production efficiency and meet global standards
Automated Cell Cultures Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Sartorius AG (Germany)
- Danaher (U.S.)
- Lonza (Switzerland)
- Nexcelom Bioscience LLC (U.S.)
- HiMedia Laboratories (India)
- Cell Culture Company, LLC (U.S.)
- Advanced Instruments (U.S.)
- SHIBUYA CORPORATION (Japan)
- NanoEntek (South Korea)
- FUJIFILM Holdings America Corporation (U.S.)
- Hitachi, Ltd. (U.S.)
- Kawasaki Heavy Industries, Ltd. (Japan)
- Sphere Fluidics Limited (U.K.)
- Thrive Bioscience (U.S.)
- Eppendorf AG (Germany)
- CellGenix GmbH (Germany)
- ChemoMetec (Denmark)
- PromoCell GmbH (Germany)
- Thermo Fisher Scientific (U.S.)
- BioSpherix, Ltd. (U.S.)
Latest Developments in Global Automated Cell Cultures Market
- In May 2024, ProPharma announced the development of the Cell Manufacturing Box (CF Box) in collaboration with PBL. This enclosed, fully automated cell manufacturing equipment enables decentralized production of various Cell & Gene Therapies (CAGT) in Class D (ISO8) or c.n.c. adjacent environments, representing a significant advancement in cell therapy manufacturing technology
- In January 2024, Thermo Fisher Scientific introduced the Gibco™ Cell Therapy Systems (CTS™) Cellmation Software, an innovative automation solution designed to integrate workflows across multiple Thermo Fisher cell therapy instruments while ensuring cGMP compliance, aimed at optimizing clinical manufacturing processes for developers of breakthrough cell therapies
- In May 2024, SINFONIA TECHNOLOGY CO., LTD. announced the delivery of two units of its CellQualia Intelligent Cell Processing (ICP) System to Keio University. These systems were delivered in March and completed their Performance Qualification in April of the same year. The devices are set to support the stable production and supply of high-quality cell medicines, crucial for advancing regenerative medicine, a promising next-generation medical treatment
- In October 2023, Molecular Devices, LLC., a prominent provider of high-performance solutions in life sciences and an operating entity within Danaher Corporation's (NYSE: DHR) life sciences segment, introduced the patent-pending CellXpress.ai Automated Cell Culture System. This innovative solution integrates an incubator, liquid handler, and imager, enhanced with machine-learning capabilities
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
